P75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma

Journal of Cutaneous Pathology

Volumn 23, Issue 3, 1996, Pages 205-210

  Kanik, A B ^a   Yaar, M ^a   Bhawan, J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR RECEPTOR; PROTEIN S 100;

ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MELANOMA; SPINDLE CELL; STAINING;

ANTIGENS, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; NEOPLASM PROTEINS; NEUROENDOCRINE TUMORS; RECEPTOR, NERVE GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR; S100 PROTEINS; STAINING AND LABELING;

EID: 0029894598     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1996.tb01468.x     Document Type: Article

References (17)

1. Carlson JA, Dickersin MD, Sober AJ, Barnhill RL. Desmoplastic neurotropic melanoma: A Clinicopathologic analysis of 28 cases. Cancer 1995: 75(2): 478.
2. Elder DE, Murphy GF. Melanocytic tumors of the skin: Atlas of tumor pathology. Third series, Rosai J, Sobin LH (eds) Fascicle 2, Washington DC.: Armed Forces Institute of Pathology, 1991:166.
3. Grown AM, Vogel AM, Hoak D, Gough F, McNutt MA. Monoclonal antibodies specific for melanocytes. Am J Pathol 1986: 123: 195.
4. Ansley A, Cerio R, Rammarain N, Orchard G, Smith N, Jones EW. Desmoplastic malignant melanoma: An immunocytochemical study of 25 cases. Am J Dermatopathol 1994: 16(1): 14.
5. Kossard S, Doherty E, Murray E. Neurotropic melanoma: a variant of desmoplastic melanoma. Arch Dermatol 1987: 123: 907.
6. Argenyi ZB, Cain C, Bromley C, et al. S100 protein negative malignant melanoma: Fact or fiction? A light microscopy and immunohistochemical study. Am J Dermatopathol 1994: 16(3): 233.
7. Ross AH, Grob P, Bothwell M, et al. Characterization of nerve growth factor receptors in neural crest tumors using monoclonal antibodies. Proc Natl Acad Sci 1984: 81: 6681.
8. Persio PM, Brooks JJ. Expression of nerve growth factor receptor in paraffin-embedded soft tissue tumors. Am J Pathol 1988: 132(1): 152.
9. Thompson SJ, Scatterman GC, Gown AM, Bothwell M. A monoclonal antibody against nerve growth factor receptor. Immunohistochemical analysis of normal and neoplastic human tissue. Am J Clin Pathol 1989: 92(4): 415.
10. Brocker EB, Magiera H, Herlyn M. Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin. J Invest Dermatol 1991: 96(5): 662.
11. Herrmann JL, Menter DG, Hamada J, Marchetti D, Nakajimma M, and Nicolson GL. Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophic receptor: melanoma p75 functions independently of trk A. Mol Biol Cell 1993: 4(11): 1205.
12. Peacocke M, Yaar M, Mansur CP, Chao MV, Gilbrest BA. Induction of nerve growth factor receptors on cultured human melanocytes. Proc Natl Acad Sci USA 1988: 85: 5282.
13. Marchetti D, Menter D, Jin L, Nakajima M, Nicholson G. Nerve growth factor effects on human and mouse melanoma cells invasion and heparinase production. Int J Cancer 1993: 55(4): 642.
14. Joseph M Verdi, Birren SJ, Ibanez CF, et al. p75 NGF-R regulates trk signal transduction and NGK-induced neuronal differentiation in MAH Cells. Neuron 1993: 12(4): 733.
15. Barrett GL, Bartlett PF. The p75 nerve growth factor receptor mediated survival or death depending on the stage of sensory neuron development. Proc Natl Acad Sci USA 1994: 9(14): 6501.
16. Donovan MJ, Hempstead B, Huber LJ, et al. Identification of the neurotrophic receptors p75 and trk in a series of Wilms' tumors. Am J Pathol 1994: 145(4): 792.
17. Rabizadeh S, Oh J, Li-Tao Zey, et al. Induction of apoptosis by low-affinity NGF receptor. Science 1993: 261: 345..